Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 20,880 shares, a growth of 456.4% from the August 15th total of 3,753 shares. Based on an average trading volume of 157,897 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the company are sold short.
Institutional Trading of Neuberger Berman High Yield Strategies Fund
Large investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in Neuberger Berman High Yield Strategies Fund in the second quarter worth approximately $113,000. Invesco Ltd. grew its position in shares of Neuberger Berman High Yield Strategies Fund by 3.5% during the 2nd quarter. Invesco Ltd. now owns 258,944 shares of the investment management company’s stock valued at $1,963,000 after acquiring an additional 8,676 shares during the period. Balyasny Asset Management L.P. purchased a new stake in shares of Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth $338,000. Osaic Holdings Inc. increased its stake in shares of Neuberger Berman High Yield Strategies Fund by 112.6% in the 2nd quarter. Osaic Holdings Inc. now owns 30,819 shares of the investment management company’s stock worth $234,000 after purchasing an additional 16,324 shares in the last quarter. Finally, SeaCrest Wealth Management LLC increased its stake in shares of Neuberger Berman High Yield Strategies Fund by 14.0% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 42,369 shares of the investment management company’s stock worth $322,000 after purchasing an additional 5,219 shares in the last quarter.
Neuberger Berman High Yield Strategies Fund Stock Down 0.5%
NHS stock traded down $0.03 during trading on Friday, reaching $5.85. The stock had a trading volume of 114,906 shares, compared to its average volume of 138,565. The stock’s 50 day moving average is $6.04 and its two-hundred day moving average is $6.39. Neuberger Berman High Yield Strategies Fund has a 52 week low of $5.85 and a 52 week high of $7.75.
Neuberger Berman High Yield Strategies Fund Announces Dividend
Neuberger Berman High Yield Strategies Fund Company Profile
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Further Reading
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
